Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
956.4 INR | +0.86% |
|
-2.26% | +47.33% |
05-23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
05-22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.33% | 1.05B | |
+17.06% | 43.26B | |
+22.54% | 21.6B | |
+21.73% | 15.93B | |
+24.35% | 15.1B | |
+58.50% | 12.95B | |
-0.05% | 6.79B | |
-14.83% | 6.29B | |
+21.38% | 6.04B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3%